Tags Reports - Allied Market Research

sale

China Oncology Drugs Market

P

2019

China Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019-2026

The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...

Report Code : A04505 | Pages : 135 | Category : Life Sciences

Price:

~~$1,806~~ $1,102 (39% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Oncology Drugs Market

P

2019

Japan Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019–2026

The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.

Report Code : A05277 | Pages : 147 | Category : Life Sciences

Price:

~~$1,806~~ $1,102 (39% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Top 10 Cancer Drugs Market

P

2023

Top 10 Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

The top 10 cancer drugs market size was valued at $77.9 billion in 2022 and is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% ...

Report Code : A05860 | Pages : 190 | Category : Life Sciences

Price:

~~$3,687~~ $2,581 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Oncology-Cancer Drugs Market

P

2024

Oncology-Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A00042 | Pages : 250 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Folliculotropic Mycosis Fungoides Treatment Market

U

2025

Folliculotropic Mycosis Fungoides Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...

Report Code : A13192 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Neuroblastoma Drugs Market

P

2024

Neuroblastoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Report Code : A172697 | Pages : 256 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

HER2-Positive Breast Cancer Market

U

2025

HER2-Positive Breast Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.

Report Code : A15411 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

Results for Tags: targeted therapy

Filter by Region

Filter by Discounts

Filter by Category

The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...

The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.

The top 10 cancer drugs market size was valued at $77.9 billion in 2022 and is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% ...

The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.